Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AtheroGenics, Inc.{AGIX}-nasdaq -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (167)	12/23/2005 2:11:44 AM
From: sim1	Read Replies (1) \| Respond to of 332

>> Does anyone know are this $50M repayable IF ARISE trial failed?<< According to what I heard Russell Medford say on the CC, the up-front $50M is a non-refundable licence fee. Later on in response to a question, it was referred to as "cash in our pocket". Also, in response to a question toward the end on breakup fees, the answer was just "normative phaseout transition fees, that's all". Conference call, about 35 minutes. Archive... vcall.com